US20020022880A1 - Device and method for restructuring heart chamber geometry - Google Patents
Device and method for restructuring heart chamber geometry Download PDFInfo
- Publication number
- US20020022880A1 US20020022880A1 US09/834,339 US83433901A US2002022880A1 US 20020022880 A1 US20020022880 A1 US 20020022880A1 US 83433901 A US83433901 A US 83433901A US 2002022880 A1 US2002022880 A1 US 2002022880A1
- Authority
- US
- United States
- Prior art keywords
- assembly
- heart
- bands
- collar
- connector bar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CC(CC*N)ICC[U] Chemical compound CC(CC*N)ICC[U] 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2478—Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
- A61F2/2481—Devices outside the heart wall, e.g. bags, strips or bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/148—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/165—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable in, on, or around the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/289—Devices for mechanical circulatory actuation assisting the residual heart function by means mechanically acting upon the patient's native heart or blood vessel structure, e.g. direct cardiac compression [DCC] devices
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Surgical Instruments (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Finger-Pressure Massage (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Percussion Or Vibration Massage (AREA)
- Massaging Devices (AREA)
Abstract
A geometric reconfiguration assembly for the natural heart having a collar configured for surrounding the natural heart. The collar can include a plurality of bands, such as thin bands of about 0.2 mm in thickness, in a spaced relationship to each other, and a connector bar intersecting the plurality of bands and configured for maintaining the spaced relationship of the bands to each other. The collar may include a plurality of bands, such as from about 2 to about 10 bands, that are positioned parallel to each other. The bands can each be made of a biomedical material, such as polyacetal or a metal, such as titanium or steel.
The connector bar of the present invention can be positioned tangential to the plurality of bands, and may have a plurality of grooves configured to receive the thickness of each of the plurality of bands. The grooves also may be beveled to allow for the bands to flex as the heart beats. The connector bar's inner surface can have an outwardly convex curved configuration, and may even include a cushioned portion that can be made from a polymeric material. A pad may be positioned between the collar and the epicardial surface of the heart that may comprise a low durometer polymer, or either a gel-filled cushion or a fluid-filled cushion.
Description
- This is a continuation in part application of U.S. patent application Ser. no. 08/581,914, filed Dec. 23, 1997, entitled “Activation Device for the Natural Heart and Method of Doing the Same,” which is a continued prosection application of U.S. patent application Ser. No. 08/581,914 filed on Jan. 2, 1996.
- The present invention relates to a device and method for treating cardiomyopathies and/or enlarged hearts and more specifically, a device and method for decreasing a heart chamber's wall tension.
- The natural heart, and specifically, the cardiac muscle tissue of the natural heart (e.g., myocardium) can fail for various reasons to a point where the natural heart cannot provide sufficient circulation of blood for a body so that life can be maintained. More specifically, the heart and its chambers can become enlarged for a variety of causes and/or reasons, including viral disease, idiopathic disease, valvular disease (mitral, aortic and/or both), ischemic disease,
- Chagas' disease and so forth. As the heart and its chambers enlarge, tension of the walls of the heart's chambers increase and thus, the heart must develop more wall tensile stress to generate the needed pressure for pumping blood through the circulatory system. The process of ventricular dilation is generally the result of chronic volume overload or specific damage to the myocardium. In a normal heart that is exposed to long-term increased cardiac output requirements, for example, that for an athlete, there is an adaptive process of slight ventricular dilation and muscle myocyte hypertrophy. In this way, the heart may fully compensate for the increase cardiac output requirements of the body. With damage to myocardium or chronic volume overload, however, there are increased requirements put on the contracting myocardium to such a level that this compensated state is never achieved and the heart continues to dilate.
- A problem with an untreated dilated ventricle is that there is a significant increase in wall tension and/or stress, both during the diastolic filling, and during the systolic contraction. In a normal heart, the adaption of muscle hypertrophy (e.g. thickening) in the ventricular dilation maintain a fairly constant wall tension for systolic constriction. However, in a failing heart, the ongoing dilation is greater than the hypertrophy, and as a result, rising wall tension is required for systolic contraction. This is believed to result in further muscle damage.
- The increase in wall stress is also true for diastolic filling. Additionally, because of the lack of cardiac output, ventricular filling pressure tends to rise due to several physiologic mechanisms. Moreover, in diastole, both the diameter and wall pressure increase over normal levels, thus contributing to higher wall stress levels. As a solution for the enlarged natural heart, attempts have been made in the past to provide a treatment to maintain circulation. Prior treatment for heart failure generally fall into three categories, namely surgical treatments; mechanical support systems; or pharmacological.
- One such approach has been to replace the existing natural heart in a patient with an artificial heart or a ventricular assist device. In using artificial hearts and/or assist devices, a particular problem stems from the fact that the materials used for the interior lining of the chambers of an artificial heart are in direct contact with the circulating blood, which can enhance undesirable clotting of the blood, build up of calcium, or otherwise inhibit the blood's normal function. Hence, thromboembolism and hemolysis could occur with greater ease. Additionally, the lining of an artificial heart or a ventricular assist device can crack, which inhibits performance, even if the crack is at a microscopic level. Moreover, these devices must be powered by a source which can be cumbersome and/or external to the body. Drawbacks have limited use of these devices to applications having too brief a time period to provide a real lasting benefit.
- An alternative procedure is to transplant a heart from another human or animal into a patient. The transplant procedure requires removing an existing organ (i.e., the natural heart) for substitution with another organ (i.e., another natural heart) from another human, or potentially, from an animal. Before replacing an existing organ with another, the substitute organ must be “matched” to the recipient, which can be, at best, difficult and time consuming to accomplish. Furthermore, even if the transplanted organ matches the recipient, a risk exists that the recipient's body will reject the transplanted organ and attack it as a foreign object. Moreover, the number of potential donor hearts is far less than the number of patients in need of a transplant. Although use of animal hearts would lessen the problem with fewer donors than recipients, there is an enhanced concern with rejection of the animal heart.
- In an effort to use the existing natural heart of a patient, other attempts have been made to reduce wall tension of the heart by removing a portion of the heart wall, such as a portion of the left ventricle in a partial left ventriculectomy procedure (the Batista procedure). A wedge-shaped portion of the ventricular muscle has been removed, which extends from the apex to the base of the heart. By reducing the chamber's volume, and thus its radius, the tension of the chamber's wall is reduced as well. There are, however, several drawbacks with such a procedure. First, a valve (i.e., the mitral valve) may need to be repaired or replaced depending on the amount of cardiac muscle tissue to be removed. Second, the procedure is invasive and traumatic to the patient. As such, blood loss and bleeding can be substantial during and after the procedure. Moreover, as can be appreciated by those skilled in the industry, the procedure is not reversible.
- Another device developed for use with an existing heart for sustaining the circulatory function of a living being and the pumping action of the natural heart is an external bypass system, such as a cardiopulmonary (heart-lung) machine. Typically, bypass systems of this type are complex and large, and, as such, are limited to short term use in an operating room during surgery, or to maintaining the circulation of a patient while awaiting receipt of a transplant heart. The size and complexity effectively prohibit use of bypass systems as a long term solution, as they are rarely even portable devices. Furthermore, long term use of these systems can damage the blood cells and blood borne products, resulting in post surgical complications such as bleeding, thromboembolism function, and increased risk of infection.
- Medicines have been used to assist in treating cardiomyopathies. Some inotropic agents can stimulate cardiac work. For example, digoxin can increase the contractibility of the heart, and thereby enhances emptying of the chambers during systolic pumping. Medicines, such as diuretics or vasodilators attempt to reduce or decrease the heart's workload. For example, indirect vasodilators, such as angiotensin-converting enzyme inhibitors (e.g., enalopril), can help reduce the tendency of the heart to dilate under the increased diastolic pressure experienced when the contractibility of the heart muscle decreases. Many of these medicines have side effects, such as excessive lowering of blood pressure, which make them undesirable for long term therapy.
- As can be seen, currently available treatments, procedures, medicines, and devices for treating end-stage cardiomyopathies have a number of shortcomings that contribute to the complexity of the procedure or device. The current procedures and therapies can be extremely invasive, only provide a benefit for a brief period of time, or have undesirable side effects which can hamper the heart's effectiveness. There exists a need in the industry for a device and procedure that can use the existing heart to provide a practical, long-term therapy to reduce wall tension of the heart, and thus improve its pumping efficiency.
- It is the object of the present invention to provide a device and method for treating cardiomyopathies that addresses and overcomes the above-mentioned problems and shortcomings in the thoracic medicine art.
- It is another object of the present invention to provide a device and method for treating cardiomyopathies that minimizes damage to the coronary circulatory and the endocardium.
- It is still a further another object of the present invention to provide a device and method for treating cardiomyopathies that maintains the stroke volume of the heart.
- Another object of the present invention is to provide a device and method for treating cardiomyopathies that supports and maintains the competence of the heart valves so that the heart valves can function as intended.
- Still another object of the present invention is to provide a device and method that increases the pumping effectiveness of the heart.
- Yet another object of the present invention is to provide a device and method for treating cardiomyopathies on a long term basis.
- It is yet still an object of the present invention to provide a device and method for treating cardiomyopathies that does not require removal of any portion of an existing natural heart.
- Still a further object of the present invention is to provide a device and method for treating dilated cardiomyopathies that directly reduce the effective radius of a chamber of a heart in systole as well as in diastole.
- Additional objects, advantages, and other features of the present invention will be set forth and will become apparent to those skilled in the art upon examination of the following, or may be learned with practice of the invention.
- To achieve the foregoing, a geometric reconfiguration assembly for the natural heart having a collar configured for surrounding the natural heart. The collar can include a plurality of bands, such as thin bands of about 0.2 mm in thickness, in a spaced relationship to each other, and a connector bar intersecting the plurality of bands and configured for maintaining the spaced relationship of the bands to each other. The collar may include a plurality of bands, such as from about 2 to about 10 bands, that are positioned parallel to each other. The bands can each be made of a biomedical material, such as polyacetal or a metal, such as titanium or steel.
- The connector bar of the present invention can be positioned tangential to the plurality of bands, and may have a plurality of grooves configured to receive the thickness of each of the plurality of bands. The grooves also may be beveled to allow for the bands to flex as the heart beats. The connector bar's inner surface can have an outwardly convex curved configuration, and may even include a cushioned portion that can be made from a polymeric material. A pad may be positioned between the collar and the epicardial surface of the heart that may comprise a low durometer polymer, or either a gel-filled cushion or a fluid-filled cushion.
- The assembly of the present invention may also comprise a closure device for enclosing at least one of the bands in the connector bar.
- In use, the present invention can reduce the wall tension on one of the chambers of the heart. A yoke or collar is surrounds the heart so as to provide the chamber of the heart as at least two contiguous communicating regions, such as sections of truncated ellipsoids, which have a lesser minimum radii than the chamber before restructuring. As such, the collar displaces at least two portions of the chamber wall inwardly from the unrestricted position.
- While the specification concludes with claims particularly pointing out and distinctly claiming the present invention, it is believed the same will be better understood from the following description taken in conjunction with the accompanied drawings in which:
- FIG. 1 partial frontal anterior view of an exemplar natural heart;
- FIG. 2 vertical cross sectional view of an exemplar natural heart and blood vessels leading to and from the natural heart;
- FIG. 3 is a horizontal cross sectional view of an unrestrained left ventricle of the natural heart;
- FIG. 4 is a horizontal cross sectional view of a heart restrained made in accordance with the present invention;
- FIG. 5 is a perspective view of a device made in accordance with the present invention;
- FIG. 6 is an enlarged exploded perspective view of a portion of the assembly made in accordance with the present invention;
- FIG. 7 is an enlarged perspective view of another portion of the assembly made in accordance with the present invention;
- FIG. 8 is a cross sectional view of a connector of the present invention taken along line8-8 in FIG. 7;
- FIG. 9A is a partial horizontal cross sectional view of an assembly made in accordance with the present invention while the heart is at rest;
- FIG. 9B is a partial horizontal cross sectional view of an assembly made in accordance with the present invention while the heart is contracting:
- FIG. 10 is a perspective view of the assembly made in accordance with the present invention and positioned in the left ventricle;
- FIG. 11 is an alternative embodiment of the assembly made in accordance with the present invention;
- FIG. 12 is a cross sectional view of one embodiment of the collar of the present invention taken along line12-12 in FIG. 11;
- FIG. 13 is another alternative embodiment of the assembly made in accordance with the present invention;
- FIG. 14 is yet another alternative embodiment of the assembly made in accordance with the invention;
- FIG. 15 is another alternative embodiment of the assembly made in accordance with the present invention;
- FIG. 16 is a vertical cross sectional view of one embodiment of an auxiliary fastener made in accordance with the present invention;
- FIG. 17 is another vertical cross sectional view of the auxiliary fastener of FIG. 16 inserted into the assembly;
- FIG. 18 the vertical cross sectional view of the embodiment of FIG. 16 illustrating the auxiliary connecter; and
- FIG. 19 is a vertical cross sectional view of the auxiliary fastener of FIG. 16 a period of time after being inserted into position.
- Referring now to the figures in detail wherein like numerals indicate the same elements throughout the views, an exemplary natural heart, generally indicated in FIGS. 1 and 2 as10, has a lower portion comprising two chambers, namely a
left ventricle 12 and aright ventricle 14, which function primarily to supply the main force that propels blood through the circulatory system, namely the pulmonary circulatory system, which propels blood to and from the lungs, and the peripheral circulatory system, which propels blood through the remainder of the body. anatural heart 10 also includes an upper portion having two chambers, aleft atrium 16 and aright atrium 18, which primarily serve as an entryway to the left andright ventricles right ventricles interventricular wall 40 ofcardiac tissue 32 separates the left andright ventricles atrioventricular wall 42 ofcardiac tissue 32 separates the lower ventricular region from the upper atrium region. - Generally, the left and
right ventricles cavity cavities left ventricle cavity 13 is in fluid communication with theleft atrium cavity 17 through themitral valve 52, while theright ventricle cavity 15 is in fluid communication with theright atrium cavity 19 through thetricuspid valve 54. - Generally, the cavities of the ventricles (e.g.,13 and 15) are each in fluid communication with the circulatory system (i.e., the pulmonary and peripheral circulatory systems) through a semilunar valve 44 (which are each illustrated as being in the open position in FIG. 2). More specifically, the
left ventricle cavity 13 is in fluid communication with theaorta 26 of the peripheral circulatory system through theaortic valve 46, while theright ventricle cavity 15 is in fluid communication with thepulmonary artery 28 of the pulmonary circulatory system through thepulmonic valve 48. - Blood is returned to the
heart 10 through the atria (e.g., 16 and 18). More specifically, thesuperior vena cava 22 andinferior vena cava 24 are in fluid communication with and deliver blood, as it returns from the peripheral circulatory system, to theright atrium 18 and itscavity 19. Thepulmonary veins 30 are in fluid communication with and delivers blood, as it returns from the pulmonary circulatory system, to theleft atrium 16, and itscavity 17. - The
heart 10 is enclosed in the thoracic cavity within a double walled sac commonly referred to as the pericardium. Its inner layer is the visceral pericardium or epicardium, and its outer layer is the parietal pericardium. Theheart 10 is generally made up of, among other materials, cardiac muscle ortissue 32, which has an exterior surface commonly known as theepicardial surface 34 and an interior surface, orendocardial surface 38, that generally defines the cavities (e.g.,ventricular cavities atrial cavities Coronary arteries 36 on theepicardial surface 34 of theheart 10 provide blood and nourishment (e.g., oxygen) to theheart 10 and itscardiac tissue 32. - By way of a non-limiting example, the present invention will be discussed in terms of embodiments that are used to primarily assist in the restructuring or reconfiguring, and/or operation of the left ventricle chamber (e.g.,12) of the
natural heart 10. However. it is noted that the present invention can also be used to assist in the restructuring or reconfiguring, and/or operation of other portions of thenatural heart 10, such as either atria (16 and/or 18), or the right ventricle chamber (e.g., 14). - Turning now to FIG. 3, the chambers of the
heart 10, including theleft ventricle chamber 12, is generally shaped as a hollow truncated ellipsoid having, at any circular cross-section perpendicular to its long axis, a center point “C1” and a radius “R1” extending from center point C1 to theendocardial surface 38. Thecardiac tissue 32 of theheart 10 has a thickness “w,” which is generally the distance between theepicardial surface 34 and theendocardial surface 38. - The
assembly 60 of the present invention exemplified in FIGS. 4 to 7 preferably is configured and positioned relative to thenatural heart 10 to displace at least two portions of thecardiac tissue 32 inwardly (see, e.g., FIG. 4) from the unrestricted position, as exemplified in FIG. 3. By displacing portions of thecardiac tissue 32 inwardly, the shape of the chamber (e.g., the left ventricle chamber 12) of theheart 10 is generally restructured or reconfigured from a generally hollow truncated ellipsoid (see, e.g., FIG. 3) to a chamber generally shaped as having at least two continuous communicating portions of truncated ellipsoids (see, e.g., FIG. 4). In generally reconfiguring or restructuring theheart 10 as such, each of the truncated ellipsoids has an adjusted radius “R2,” which is preferably shorter than radius “R1.” - The
assembly 60 can be static in that it does not actuate or pump theheart 10, but rather, displaces and holds portions of thecardiac tissue 32 in a generally predetermined fixed position as theheart 10 continues to contract (e.g., beat) and pump blood through its chambers and through the body's circulatory system. Nevertheless, theassembly 60 can be configured and constructed to permit torsional deformation as thenatural heart 10 beats. - The
assembly 60 can include a yoke orcollar 62, as exemplified in FIGS. 5-7, to assist in restraining or restructuring a ventricle, such as theleft ventricle chamber 12.Collar 62 can be any desired shape and preferably surrounds or encircles theheart 10, and preferably one chamber (e.g., the left ventricle chamber 12) as best exemplified in FIG. 10, so as to restructure or reconfigure theleft ventricle chamber 12 as having a shape approximating at least two continuous communicating portions of truncated ellipsoids. Preferably, a portion orregion 64 of thecollar 62 can extend along the longitudinal plane or along the longer axis of the chamber. Suitable locations on theepicardial surface 34 for theregion 64 can include the basal portion near the atrioventricular groove 43 (see, e.g., FIG. 1) andapical portion 20 of theheart 10, the anterolateral surface of theleft ventricle chamber 12, or the posteromedial surface of theleft ventricle chamber 12. - The
collar 62 may include two or more bands (e.g., 76) configured for positioning around theheart 10. Preferably,bands 76 are circumferentially flat and may be oriented with thesurface 78 being positioned generally tangent to theepicardial surface 34 of theheart 10, and having the smaller dimension, as compared withsurface 80.Surface 80 is generally oriented perpendicular to theepicardial surface 34.Band 76 should be sized so as to provide for low deformation in the direction perpendicular to theepicardial surface 34 of theheart 10, but only require a low strain energy for tortial deformation as the heart 1O beats.Band 76 can have a thickness “th” acrosssurface 78 and a width “w” acrosssurface 80, that each varies depending on the selected material and its particular deformation characteristics. When metallic material is used with the present invention, theband 76 can have a thickness “h” acrosssurface 78 of about 0.2 mm, and can have a width, “w” acrosssurface 80 from about 5 mm to about 12 mm, and more preferably, about 7 mm. It should be noted that the particular dimensions of eachassembly 60, and of its components (e.g. collar 62 and its various portions,bands 76, etc.) will depend, as will be discussed later, according to particular anatomy, the desired application, and upon the particular size and configuration of the individualnatural heart 10. - In constructing
assembly 60 usingbands 76, from about 2 to about 10bands 76 may be used, and preferably about 4bands 76 are used in the present invention. Nevertheless, the number ofbands 76 may be selected dependent upon the property of the material selected for each of thebands 76, as well as the load stress required to appropriately restructure the heart chamber geometry. -
Bands 76 are each preferably made of a light weight, generally rigid material that has a low bending strain under expected levels of stress so that the material has sufficient wear resistance in use while theheart 10 beats, and maintains its desired shape in use adjacent theheart 10. Illustrative examples of suitable materials which may be employed asbands 76 include any biocompatible or biomedical materials, such as metals, including titanium or stainless steel, or a suitable polymer, including polyacetal or an ultra high molecular weight polyethylene, or a combination of the same. - The
collar 62 may preferably include aconnector 82, and preferably a plurality ofconnectors 82 spaced along thecollar 62, as exemplified best in FIG. 5. Theconnectors 82 can assist in maintaining the space relationship of thebands 76 relative to each other, and of theassembly 60 to theheart 10. Turning now to FIGS. 6-8, theconnector 82 preferably has a contact or aninner surface 84, which is configured for placement adjacent or against theepicardial surface 34 of thenatural heart 10. Theinner surface 84 may be configured so that theepicardial surface 34 may slide alonginner surface 84 during contraction and expansion of theheart 10, and to minimize damage to theepicardial surface 34, and the coronary arteries (e.g., 36). Preferably, theinner surface 84 is curved convex outwardly in a longitudinal plane (see, e.g., FIGS. 4 and 8) and has a smooth surface, and/or preferably roundededges 87 so thatcollar 62 can be configured to be positioned adjacent or on theepicardial surface 34 whereby intimate contact can be established and maintained, even during the contraction or beating of theheart 10. - FIGS.6-8 illustrate the
connectors 82 as each including one ormore grooves 92, which can extend inwardly from anopening 98 in theouter wall 86, and toward the contact orinner surface 84. Eachgroove 92 is preferably sized and configured to receive aband 76 whereby itssurface 78 would be positioned adjacent thebase wall 94, and itssurfaces 80 preferably would be positionedadjacent sidewalls 96. - In an preferred embodiment, groove92 should be configured to assist in allowing flexion movement of the
band 76 as theheart 10 beats and moves. As best exemplified in FIGS. 6-8,grooves 92 may be tapered inwardly as thegrooves 92 proceeds or extends from theouter surface 86 inwardly toward thecontact surface 84. In addition,grooves 92 may also be tapered inwardly as the groove extends from each of the lateral surfaces 88 inwardly (e.g., upwardly and/or downwardly), as best illustrated in FIG. 6. -
Connectors 82 are each preferably made of a light weight, generally rigid material that has a low bending strain under expected levels of stress so that the material has sufficient wear resistance in use while theheart 10 beats, and maintains its desired shape in use adjacent theheart 10. Illustrative examples of suitable materials which may be employed asconnectors 82 may include any biocompatible or biomedical materials, such as metals, including titanium or stainless steel, or a suitable polymer, including polyacetal or an ultra high molecular weight polyethylene, or a combination of the same. - Turning back to FIG. 6, a
structure 100 can be provided so as to assist in maintaining thebands 76 in thegroove 92, in use. Anystructure 100 contemplated for use withassembly 60 should assist in restricting movement of theband 76 out of thegroove 92 throughopening 98. In one embodiment, thestructure 100 may take the form of aplate 100 that can be secured or otherwise attached, and preferably releasably secured, to close off or restrict access through one ormore openings 98. In addition to a plate-like structure, sutures (not shown) may also be threaded through theconnector 82 to assist in restrictingbands 76 movement throughopening 98.Structure 100 is preferably made of a biocompatible or biomedical material. - Turning now to FIGS. 11 and 12, an alternative embodiment of the present invention may include a collar or
yoke 162 that provides an essentially continuous surface which contacts theepicardium surface 34 of theheart 10. In the present embodiment,collar 162 may take the form of a generally continuous yoke-like structure that is essentially rigid.Collar 162 preferably includes a contact or aninner surface 184, which is configured for placement adjacent or against theepicardial surface 34 of thenatural heart 10. Theinner surface 184 should be configured so that theepicardial surface 34 may slide along theinner surface 184 during contraction and expansion of thenatural heart 10, and to minimize damage to theepicardial surface 34 and the coronary arteries (e.g., 36). Preferably, theinner surface 184 is curved convexly outwardly in a longitudinal plane and has a smooth surface, and/or preferably roundededges 187 so that acollar 162 can be configured to be positioned adjacent or on theepicardial surface 34 whereby intimate contact can be established arid maintained, even during the contraction or expansion of thenatural heart 10. - The
collar 162 preferably is selected from a generally rigid biomedical or biocompatable material. Examples of such suitable materials may include a metal, such as titanium or steel, or a polymer, such as an ultra high molecular weight polyethylene, polyacetal, or a polymer composite material such as carbon fiber-epoxy or fiberglass-epoxy, or a combination of the same. Moreover, thecollar 162 may be covered, either partially or entirely, with a material that promotes tissue ingrowth into thecollar 162, such as a soft tissue polyester fabric sheeting or polyletrafluroethyhere (PTFE). - In another alternative embodiments, exemplified in FIGS.13-14, it is contemplated that the
collar 162 may include anattachment system 163 that allows thecollar 162 to be placed around theheart 10, such as inbetween thepulmonary veins 30 near the basal portion of theheart 10 so as to reduce the possibility of lateral or medical displacement of theassembly 60, or about the lateral atrium or the atrioventrialar groove region. In one embodiment, thecollar 162 may include anattachment system 163 that permits thecollar 162 to be separated and then reattached at two or more sites or positions along thecollar 162, preferably adjacent or near the region of thecollar 162 configured for placement adjacent or on the basal portion and/orapical portion 20 of thenatural heart 10. While theattachment system 163 is illustrated as an interlockingpin 163B andreceptacle 163A (e.g., a ball and socket-likejoint), it is contemplated, and as would be appreciated by those skilled in the art, other devices and assemblies for releaseably securing thecollar 162 together can be used. Example of such devices and assemblies forattachment system 163 could include sutures, a screw and bore holes through overlapping portions of thecollar 162, clamps, a combination of these devices and assemblies. - Alternatively, as illustrated in FIG. 14, the
collar 162 may include anattachment system 163 at one site along thecollar 162, preferably adjacent or at the portion of thecollar 162 configured for placement adjacent on or the basal portion of theheart 10. This embodiment ofcollar 162 preferably would include aportion 167 that can either include flexible material or apivotable section 168 to provide movement of thecollar 162 so that theattachment assembly 163 can open, and thecollar 162 can be slipped around in theheart 10, and/or between thepulmonary veins 30. - In yet another embodiment illustrated in FIG. 15, the
assembly 260 may include acollar 262 having aregion 264 similar to the structure of thecollar 62, exemplified above in FIGS. 4-8, and connector portions orregions 268, similar to the structure of thecollar 162, discussed above, and exemplified in FIGS. 12-14. - To assist the
epicardial surface 34 in separating from each of thecollars lateral portions 85 ofinner surface 84 without creating substantial negative pressure, apad 56 can be positioned and/or interposed between theepicardial surface 34 and theinner surface 84 of one or more of theconnectors 82.Pad 56 can be, as exemplified in FIGS. 9A and 9B, a fluid-filled or gel-filled pad or cushion, which generally will occupy space laterally beyond thecollar 62 and thelateral portions 85 ofinner surface 84 while theheart 10 is in as a relaxed state. However, as theheart 10 contracts and the wall shortens (see, e.g., FIG. 9B), generally circumferentially (reducing cavity radius), theepicardial surface 34 will “peel away” from thecollar 62 and thelateral portions 85 ofinner surface 84 and thus, fluid or gel in thepads 56 can fill this space so that theinner surface 84 andepicardial surface 34 remain in contact and effect focal restraint whereby thechamber 12 is restructured, as detailed above. - In one embodiment, the
pad 56 is a closed system. Alternatively, it is contemplated thatpad 56 can be configured such that fluid and/or gel can be added or removed to enhance functionality of the device assembly of the present invention, as desired. For example, one ormore lines 58 can be in fluid communication with a chamber inpad 56.Line 58 can extend frompad 56 to aninjection port 59, which can be positioned subcutaneous or elsewhere, as desired, for enhanced access. As will be appreciated by those skilled in the art, fluid or gel can be injected into theinjection port 59 using a standard syringe and needle, or other device, to increase the size of thepad 56 and/or the pressure within thepad 56, as desired. Alternatively, fluid or gel can be withdrawn as desired. - Alternatively, pad56 can be as a low durometer polymer such as a plastic or other material (e.g., rubber). In use, as detailed above, the-material accommodates and maintains the contact between the
collar 62, and more specifically itsinner surface 84, andepicardial surface 34 and thus, the desired reconfiguration of theheart 10 as theheart 10 beats or deforms. - To assist each of the
assembly 60 in remaining fixed in a spatial or spaced relationship to each other and adjacent or on theepicardial surface 34, as desired, one or moreauxiliary connectors 70 is provided.Auxiliary connector 70 can take the form of various mechanical connectors used in the industry to attach and position prosthetic devices in the body. -
Auxiliary connector 70 can take the form of a spike shaped object or pin 75 that is configured to penetrate theepicardial surface 34 into thecardiac tissue 32. Also,auxiliary connector 74 can take the form of abutton 72 andcord 73. One end of thecord 73 can be attached or otherwise secured to thecollar 62, and it can extend inwardly into and through thecardiac tissue 32. Abutton 72 can be attached to or adjacent the other end of thecord 86 adjacent theendocardial surface 38.Button 72 can be made of any biocompatible material, and is preferably made of a material that enhances tissue growth around thebutton 72 to minimize the possibility of the formation of blood clots. It is further contemplated that other surgical attachment articles and techniques can be used in accordance with the present invention, such as screws, surgical staples and the like, to assist in fastening and securing theassembly 60 in position, as desired. - Furthermore,
auxiliary connector 70 can take the form of apeg 74, as exemplified in FIGS. 16-19, that can configured to be lockably received in ahole 67 positioned and/or aligned on theassembly 60, and preferably on theconnectors 82 or thecollar 162.Peg 74 generally comprises a generallypermanent potion 74A configured preferably to be snugly received in thehole 67, as discussed above. Theportion 74A can be made of any suitable biomedical or biocompatible material. Suitable examples of materials forportion 74A, can include the same materials that can be used with thecollar 62, as exemplified above. - At the end of the
portion 74A of thepeg 74, a generally rigidabsorbable spike 74B is provided, which preferably is a generally fustoconicall shaped and tapers inwardly as thespike 74B extends away from theportion 74A.Spike 74B is sufficiently rigid so that it can pierce the tissue and then be inserted into the muscle tissue (e.g., the cardiac tissue 32). The material used forspike 74B should be a material that is absorbable by the body tissue over a period of time. Suitable materials can include a gelatin material, which can be partially denatured thermally or chemically to control solubility and the absorption rate in the tissue (e.g., 32), a polyglycol acid, or other materials, as will be appreciated by those skilled in the industry, used with absorbable surgical devices or sutures. - Within the
portion 74A and spike 74B is a generallyflexible extension 74C configured, for example, as a strip, coil, tube, or loop which preferably may include exposed interstices (mesh), holes, loops or other surface enhancements to promote tissue in growth.Extension 74C can be made from a material to enhance tissue integration therein. Suitable examples of materials for use asextension 74C can include polyester, polypropylene, and other polymers used in as non-dissoluble implants. - In accordance with the teachings of the present invention, the
assembly 60 should be so configured and positioned adjacent theheart 10 whereby the wall tension is reduced in accordance with LaPlace's theory of a chamber, which is as follows: - (Tension of wall)=K*(chamber pressure)*(radius of chamber)(wall thickness),
- wherein K is a proportionality constant.
- As an illustrative example of one embodiment in accordance with the teachings of the present invention, calculations will be performed based on the following model as exemplified in FIGS. 3 and 5. It is assumed that the long axis of the
left ventricle 12 of theheart 10 is 100 mm, that the equatorial or short axis of thechamber 12 is 70 mm, that the equatorial wall thickness “w” of the chamber is about 10 mm and the basal diameter of theheart 10 is 60 mm. An arbitrary slice or plane of theleft ventricle 12 will be analyzed to illustrate local dimensional computations for the present invention. - Furthermore, this model will assume that the inner radius “R1” (of the slice or plane) of the unrestricted heart 10 (see, e.g., FIG. 3) is about 28.982 mm and that the
heart 10 has an outer radius of about 38.406 mm. As is known to those skilled in the industry, the width “w” and radius “R1” can be directly obtained from high-resolution imaging, such as an echocardiogram, or preferably, by computation based on an assumed geometric model. The ratio of the restraint contract pressure of theleft ventricle 12 of thedevice 60 to the cavity pressure can vary from 1 to about 2. This example will further assume that the allowed ratio of the restraint contact pressure of theleft ventricle 12 ofdevice 60 to the cavity pressure is to be limited to a maximum of about 1.5, which is represented by symbol K in the mathematical formulas below. Also, it is desired to achieve an altered radius “R2” of theleft ventricle 12 to 80% of its original radius R1, and as such: - R2=0.8*R1
- R2=0.8*28.982 mm
- R2=23.186 mm
- In order to calculate the radius of curvature “g” of the
inner surface 64 ofmember 62 in the transverse plane, the following formula can be used: - g=(w+R2)÷(k−1)
- g=(9.424 mm+23.186 mm)÷(1.5−1)
- g=(32.61 mm)÷0.5
- g=65.22 mm.
- Now that the value of radius of curvature of the
inner surface 84 “g” has been calculated, the angle “θ” between the line g1 (joining the center of curvature of themember 62 with one margin, in this plane, of the contact area betweeninner surface 84 and the epicardial surface 34) and line g2 (joining the same center of curvature with the center of theinner surface 84 in the same plane) can be calculated using the following formula: - θ=(π/2)*[R 2 −R 1]÷(R 2 +w+g)
- θ=(π/2)*[28.982 mm −23.186 mm]÷(28.982 mm+9.424 mm+65.22 mm)
- θ=(π/2)*[5.796 mm]÷(103.636 mm)
- θ=0.09063 radius or 5.332 degrees
- Using the formula below, the distance inwardly that the
heart 10 should be displaced can be calculated so that the desired restructuring can be achieved. If “e” is the distance that the center of eithermember 62 is to be separated from the absolute center of a remodeled ventricle in this plane, then: - e=[(g+w+R 2)* cos θ]−g
- e=[(65.22 mm+9.424 mm+23.186 mm)* cos 5.332 degrees]−65.22 mm
- e=32.21 mm.
- As such, twice e or (2*e) is 64.42 mm, and this is the preferred distance separating the oppositely disposed
inner surfaces 64. - Based on the calculation, the wall of the
heart 10 needs to be displaced or moved inwardly about 6.20 mm from the unrestrained position to achieve the desired restructure or reconfiguration whereby wall tension is adjusted, as desired. Also, using the formula 2θg to calculate the desired contacting width of theinner surface 84, which is about 11.68 mm in this example. - To position the
assembly 60 into a body (e.g., the thoracic cavity) and around an existingnatural heart 10, a high resolution image, such as a standard echocardiogram, or other analysis of theheart 10 is preferred so that certain anatomical measurements can be electronically, preferably digitally, recorded and calculated, as detailed above. While the present application only includes one set of mathematic calculations to optimize the present invention, it is contemplated that measurements will need to be taken along several axes, planes, locations or positions along the longer axis of the chamber. Pre-surgical calculations are preferred so that theassembly 60 can be constructed, as desired, before surgery to minimize surgical time, and preferably reduce or eliminate use of a heart/lung bypass machine. - Thoracic surgery may be required to implant
assembly 60. Clinically sufficient anesthesia is administered and standard cardiac monitoring is employed to the patient and then, via a sternal or lateral wall incision, the pericardial sac where theheart 10 is usually situated is opened using standard thoracic surgical procedures, which are known to those skilled in the art. - Once the thoracic cavity and pericardium is opened, the
heart 10 must be narrowed or constricted so that theassembly 60 can be placed around theheart 10. In one embodiment, inflow to theheart 10 may be occluded. This can be accomplished by placing a tourniquet around either the superior and/orinferior vena cava heart 10 shrinks and empties. Thereafter, thecollar 62 may be slipped around theheart 10. The tourniquets can be released from occlusion around the superior and/orinferior vena cavas heart 10 re-fills with blood. - While for prolonged reduction of blood pressure by cardiac inflow occlusion, hypothennia techniques may be employed to lower body temperature to reduce the side effects that can be caused by reduced blood pressure in the circulatory system.
- If an open heart procedure employed in the present invention, circulation of blood to the
natural heart 10 may be bypassed so the present invention can be inserted on and/or into the patient. If so, referring back now to FIG. 2, thesuperior vena cava 22, theinferior vena cava 24, andaorta 26 are cannulated. The circulatory system is connected to as a cardiopulmonary bypass machine so that circulation and oxidation of the blood are maintained during the surgical procedure. By way of example, the procedure discussed in detail will be for insertion of thepresent invention 60 to restructure or reconfigure theleft ventricle chamber 12. - Turning now to FIGS.4-7 and 10,
assembly 60, which may have been customized according to the anatomical measurements and calculations, is preferably positioned adjacent or against theepicardial surface 34 in predetermined locations relative to each other and relative to the chamber (e.g., left ventricle chamber 12).Assembly 60 is positioned around theheart 10 so that portions of theheart 10 are displaced or urged inwardly, as desired. -
Auxiliary connectors 70 can be used to further secure theassembly 60 to theheart 10. Turning now to FIGS. 16-19, peg 74 can be inserted in thehole 67, whereby thespike 74B is piercing theepicardial surface 34 and is being inserted into the tissue (e.g., cardiac tissue 32).Peg 74 preferably locks into position once inserted (see FIG. 17), to further secure theassembly 60 in place. Over time, it is preferred that spike 74B, which has been inserted into the tissue, dissolve and be absorbed by the surrounding tissue. As thespike 74B is being absorbed,extension 74C becomes exposed to the tissue, and tissue thereby insinuates and grows into any exposed interstices, loops, holes, or other surface enhancements to promote tissue ingrowth. Thepeg 74B can thereafter be held in place by the tissue insinuation and growth intoextension 74C, which can assist in maintaining the position ofassembly 60. - Once the
assembly 60 is properly positioned and secured, termination of a cardiopulmonary bypass, if used, is attempted and, if successful, the thoracotomy is closed. - Alternatively, once the thoracic cavity and pericardium is open, the
collar 162 exemplified in FIGS. 13 and 14, can be placed around theheart 10, either between thepulmonary artery 28 and the superior left atrial surface or between the aorta and thepulmonary artery 28 and then across the posterior dorsal left atrial surface in between the left and rightpulmonary veins 30. A portion of thecollar 162, preferably the posterior portion, can be placed behind theheart 10. An opening is sharply and/or bluntly developed in the leaves of the pericardium forming the anterolateral margin of the oblique sinus. Then, a hemostat can be used to place a portion of thecollar 162 through the opening. Alternatively, a detachable cord, with one end attached to the portion of thecollar 162, can be grasped and used to pull a portion of thecollar 162 through the opening. Such placement of thecollar 162 across theepicardial surface 34 of the lateral atrium or atrioventricular junction should reduce the possibility of adverse medial or lateral displacement or movement of thecollar 162. - An alternative method for positioning the present invention includes removing the
natural heart 10 from the patient, positioning all the components of thepresent invention assembly 60, as discussed above, and auto-transplanting thenatural heart 10 back into the patient using standard cardiectomy and cardiac transplant techniques known in the industry. - Having shown and described the preferred embodiments to the present invention, further adaptations of the activation device for the living heart as described herein can be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. For example, the present invention can be used with any one or even as a plurality of the various chambers of a living heart, and also could be used with different structural embodiments to restructure he chamber. Several such potential modifications have been discussed and others will be apparent to those skilled in the art. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited in the details, structure and operation shown and described in its specification and drawings.
Claims (26)
1. A geometric reconfiguration assembly for a natural heart, comprising:
a collar configured for surrounding the natural heart and having a plurality of bands in a spaced relationship; and
a connector bar intersecting the plurality of bands and configured for maintaining the spaced relationship of the bands to each other.
2. The assembly of claim 1 , wherein the connector bar comprises an inner surface having an outwardly convex curved configuration.
3. The assembly of claim 1 , wherein each of the plurality of bands are positioned parallel to each other.
4. The assembly of claim 1 , wherein the assembly comprises from about 2 to about 10 bands.
5. The assembly of claim 1 , wherein the bands comprise a high strength, high modulus polymer.
6. The assembly of claim 1 , wherein the bands comprise a metal.
7. The assembly of claim 1 , wherein the connector bar is positioned tangential to the plurality of bands.
8. The assembly of claim 1 , wherein at least one of the bands has a thickness of about 0.2 mm.
9. The assembly of claim 1 , wherein each of the bands includes a thickness, and the connector bar comprises a plurality of grooves configured to receive the thickness of each of the plurality of bands.
10. The assembly of claim 9 , wherein the connector bar comprises at least one beveled groove.
11. The assembly of claim 1 , wherein the connector bar comprises a cushioned portion.
12. The assembly of claim 1 , comprises a closure device for enclosing at least one of the bands in the connector bar.
13. The assembly of claim 1 , wherein the collar comprises a first restrictor region configured to be positioned adjacent the anterolateral surface of the heart and a second restrictor region configured to be positioned adjacent posteromedial surface of the heart.
14. The assembly of claim 11 , wherein the cushion portion comprises a polymeric material.
15. The assembly of claim 1 , wherein said assembly comprises a pad provided adjacent the inner surface of the connector bar.
16. The assembly of claim 15 , wherein the pad comprises a low durometer polymer.
17. The assembly of claim 15 , wherein the pad comprises a cushion.
18. The device of claim 17 , wherein the cushion comprises a gel-filled cushion.
19. The assembly of claim 17 , wherein the cushion comprises a fluid-filled cushion.
20. A geometric reconfiguration assembly for a natural heart, comprising;
a collar for surrounding a portion of the natural heart, said collar having a portion configured for placement on the basal portion of the natural heart in between the left and right pulmonary veins, said collar further comprising an attachment assembly configured for releasably connecting said collar together.
21. The assembly of claim 20 , wherein the collar comprises an inner surface having a outwardly convex curve configuration.
22. The assembly of claim 20 , wherein the attachment system comprises a pin and receptacle, said pin and receptacle being releasably detachable.
23. A geometric reconfiguration assembly for a natural heart, comprising
a collar configured for surrounding a natural heart, said collar having a first restrictor region for placement adjacent the anterolateral surface of the heart, and a second restrictor region configured for positioning adjacent the posteromedial surface of the heart; the first and second restrictor portions each comprising a plurality of bands in a space relationship and a connector bar intersecting the plurality of band and configured for maintaining the space relationship of the bands to each other.
24. The assembly of claim 23 , wherein the collar comprises a first and second connector portion configured for placement adjacent the basal portion of the heart and a second connector portion configured for a position adjacent the apical portion of the epicardium of the heart.
25. A method for reducing wall tension on one of the chambers of the heart, comprising the steps of
providing a geometric reconfiguration assembly; and
surrounding one of the chambers of the heart with a geometric configuration assembly.
26. The method of claim 25 , comprising the step of occluding blood inflow into the heart prior to placement of the assembly around the chamber of the heart.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/834,339 US20020022880A1 (en) | 1996-01-02 | 2001-04-13 | Device and method for restructuring heart chamber geometry |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/581,914 US5957977A (en) | 1996-01-02 | 1996-01-02 | Activation device for the natural heart including internal and external support structures |
US09/165,887 US6221103B1 (en) | 1996-01-02 | 1998-09-30 | Device and method for restructuring heart chamber geometry |
US09/834,339 US20020022880A1 (en) | 1996-01-02 | 2001-04-13 | Device and method for restructuring heart chamber geometry |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/165,887 Continuation US6221103B1 (en) | 1996-01-02 | 1998-09-30 | Device and method for restructuring heart chamber geometry |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020022880A1 true US20020022880A1 (en) | 2002-02-21 |
Family
ID=24327080
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/581,914 Expired - Fee Related US5957977A (en) | 1996-01-02 | 1996-01-02 | Activation device for the natural heart including internal and external support structures |
US09/165,887 Expired - Fee Related US6221103B1 (en) | 1996-01-02 | 1998-09-30 | Device and method for restructuring heart chamber geometry |
US09/834,339 Abandoned US20020022880A1 (en) | 1996-01-02 | 2001-04-13 | Device and method for restructuring heart chamber geometry |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/581,914 Expired - Fee Related US5957977A (en) | 1996-01-02 | 1996-01-02 | Activation device for the natural heart including internal and external support structures |
US09/165,887 Expired - Fee Related US6221103B1 (en) | 1996-01-02 | 1998-09-30 | Device and method for restructuring heart chamber geometry |
Country Status (7)
Country | Link |
---|---|
US (3) | US5957977A (en) |
EP (2) | EP0874614B1 (en) |
AT (1) | ATE253346T1 (en) |
AU (1) | AU1532597A (en) |
CA (1) | CA2242412C (en) |
DE (1) | DE69725962T2 (en) |
WO (1) | WO1997024101A1 (en) |
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010018611A1 (en) * | 1999-06-30 | 2001-08-30 | Solem Jan Otto | Method and device for treatment of mitral insufficiency |
US20020019580A1 (en) * | 2000-03-10 | 2002-02-14 | Lilip Lau | Expandable cardiac harness for treating congestive heart failure |
US20020077524A1 (en) * | 1997-01-02 | 2002-06-20 | Myocor, Inc. | Heart wall tension reduction apparatus |
US20020151961A1 (en) * | 2000-01-31 | 2002-10-17 | Lashinski Randall T. | Medical system and method for remodeling an extravascular tissue structure |
US20020169359A1 (en) * | 1997-01-02 | 2002-11-14 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US20030050529A1 (en) * | 2000-03-21 | 2003-03-13 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US20030135267A1 (en) * | 2002-01-11 | 2003-07-17 | Solem Jan Otto | Delayed memory device |
US20030153949A1 (en) * | 2001-10-31 | 2003-08-14 | Lilip Lau | Heart failure treatment device and method |
US6612978B2 (en) | 1999-12-22 | 2003-09-02 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US20030181928A1 (en) * | 2000-10-06 | 2003-09-25 | Myocor, Inc. | Endovascular splinting devices and methods |
US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US20040039443A1 (en) * | 1999-06-30 | 2004-02-26 | Solem Jan Otto | Method and device for treatment of mitral insufficiency |
US20040055608A1 (en) * | 1993-02-22 | 2004-03-25 | Ethicon, Inc. | Minimally-invasive devices and methods for treatment of congestive heart failure |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US20040102841A1 (en) * | 2000-01-31 | 2004-05-27 | Langberg Jonathan J. | Percutaneous mitral annuloplasty with cardiac rhythm management |
US6746471B2 (en) | 1998-07-29 | 2004-06-08 | Myocor, Inc. | Transventricular implant tools and devices |
US20040127983A1 (en) * | 1997-12-17 | 2004-07-01 | Myocor, Inc. | Valve to myocardium tension members device and method |
US20040133220A1 (en) * | 2000-01-31 | 2004-07-08 | Randall Lashinski | Adjustable transluminal annuloplasty system |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US20040143156A1 (en) * | 2001-09-10 | 2004-07-22 | Lilip Lau | Device for treating heart failure |
US20040148019A1 (en) * | 2002-11-12 | 2004-07-29 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US20040148020A1 (en) * | 2002-11-12 | 2004-07-29 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US6802319B2 (en) | 1993-02-22 | 2004-10-12 | John H. Stevens | Minimally-invasive devices and methods for treatment of congestive heart failure |
US20040210104A1 (en) * | 2002-11-15 | 2004-10-21 | Lilip Lau | Cardiac harness delivery device and method |
US6808488B2 (en) | 1998-09-21 | 2004-10-26 | Myocor, Inc. | External stress reduction device and method |
US20040249242A1 (en) * | 2003-03-28 | 2004-12-09 | Lilip Lau | Multi-panel cardiac harness |
US20040254600A1 (en) * | 2003-02-26 | 2004-12-16 | David Zarbatany | Methods and devices for endovascular mitral valve correction from the left coronary sinus |
US20050043792A1 (en) * | 1999-06-29 | 2005-02-24 | Edwards Lifesciences Ag | Device and method for treatment of mitral insufficiency |
US20050054892A1 (en) * | 2003-07-10 | 2005-03-10 | Lilip Lau | Self-anchoring cardiac harness |
US20050059855A1 (en) * | 2002-11-15 | 2005-03-17 | Lilip Lau | Cardiac harness delivery device and method |
US20050080483A1 (en) * | 2001-12-28 | 2005-04-14 | Solem Jan Otto | Delayed memory device |
US20050085903A1 (en) * | 2003-10-17 | 2005-04-21 | Jan Lau | Heart valve leaflet locator |
US20050096740A1 (en) * | 2001-01-30 | 2005-05-05 | Edwards Lifesciences Ag | Transluminal mitral annuloplasty |
US20050102010A1 (en) * | 2003-11-07 | 2005-05-12 | Lilip Lau | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US20050102013A1 (en) * | 2003-11-07 | 2005-05-12 | Lilip Lau | Cardiac harness for treating heart disease |
US20050137673A1 (en) * | 2003-11-07 | 2005-06-23 | Lilip Lau | Cardiac harness having electrodes and epicardial leads |
US20050154253A1 (en) * | 2004-01-12 | 2005-07-14 | Lilip Lau | Cardiac harness having interconnected strands |
US20050171589A1 (en) * | 2003-11-07 | 2005-08-04 | Lilip Lau | Cardiac harness and method of delivery by minimally invasive access |
US20050177228A1 (en) * | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
US20050222678A1 (en) * | 2004-04-05 | 2005-10-06 | Lashinski Randall T | Remotely adjustable coronary sinus implant |
US20050256368A1 (en) * | 2002-11-15 | 2005-11-17 | Paracor Medical, Inc. | Introducer for a cardiac harness delivery |
US20050283042A1 (en) * | 2003-03-28 | 2005-12-22 | Steve Meyer | Cardiac harness having radiopaque coating and method of use |
US20060009675A1 (en) * | 2004-07-08 | 2006-01-12 | Steven Meyer | Self-anchoring cardiac harness for treating the heart and for defibrillating and/or pacing/sensing |
US20060129051A1 (en) * | 2004-12-09 | 2006-06-15 | Rowe Stanton J | Diagnostic kit to assist with heart valve annulus adjustment |
US20060129026A1 (en) * | 2004-12-15 | 2006-06-15 | Joshua Wallin | Apparatus and method for mounting a cardiac harness on the heart |
US20060247491A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for heart valve treatment |
US20070027516A1 (en) * | 2005-08-01 | 2007-02-01 | Alan Schaer | Cardiac harness having an optimal impedance range |
US20070032696A1 (en) * | 2005-07-22 | 2007-02-08 | Sieu Duong | Cardiac harness delivery device |
US20070055091A1 (en) * | 2004-12-02 | 2007-03-08 | Lilip Lau | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US20070106359A1 (en) * | 2003-11-07 | 2007-05-10 | Alan Schaer | Cardiac harness assembly for treating congestive heart failure and for pacing/sensing |
US20070106336A1 (en) * | 2003-11-07 | 2007-05-10 | Alan Schaer | Cardiac harness assembly for treating congestive heart failure and for pacing/sensing |
US20070129598A1 (en) * | 2001-09-07 | 2007-06-07 | Raman Jaishanker | Method and apparatus for external stabilization of the heart |
US20070255093A1 (en) * | 2002-11-15 | 2007-11-01 | Lilip Lau | Cardiac harness delivery device and method |
US20070287883A1 (en) * | 2006-06-07 | 2007-12-13 | Lilip Lau | Apparatus and method for pulling a cardiac harness onto a heart |
US20090048480A1 (en) * | 2007-08-13 | 2009-02-19 | Paracor Medical, Inc. | Cardiac harness delivery device |
US20090156892A1 (en) * | 2002-09-05 | 2009-06-18 | Paracor Medical, Inc. | Cardiac harness |
US20090281372A1 (en) * | 2008-05-06 | 2009-11-12 | Paracor Medical, Inc. | Cardiac harness assembly for treating congestive heart failure and for defibrillation and/or pacing/sensing |
US7695512B2 (en) | 2000-01-31 | 2010-04-13 | Edwards Lifesciences Ag | Remotely activated mitral annuloplasty system and methods |
US20100274076A1 (en) * | 1997-01-02 | 2010-10-28 | Edwards Lifesciences Llc | Heart Wall Tension Reduction Apparatus and Method |
US20100298935A1 (en) * | 2007-09-12 | 2010-11-25 | Surgical Energetics, Inc. | Medical Device and Tension Member for Use in a Subject |
US20110004053A1 (en) * | 2007-12-05 | 2011-01-06 | Surgical Energetics, Inc. | bolster for securing a septal splint to a cardiac wall, a method of use thereof, and a system including the same |
US7976454B2 (en) | 2002-01-07 | 2011-07-12 | Paracor Medical, Inc. | Cardiac harness |
US8192351B2 (en) | 2007-08-13 | 2012-06-05 | Paracor Medical, Inc. | Medical device delivery system having integrated introducer |
US8439817B2 (en) | 1998-07-29 | 2013-05-14 | Edwards Lifesciences, Llc | Chordae capturing methods for stress reduction |
US9375218B2 (en) | 2006-05-03 | 2016-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US10485545B2 (en) | 2013-11-19 | 2019-11-26 | Datascope Corp. | Fastener applicator with interlock |
US11653928B2 (en) | 2018-03-28 | 2023-05-23 | Datascope Corp. | Device for atrial appendage exclusion |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6592619B2 (en) * | 1996-01-02 | 2003-07-15 | University Of Cincinnati | Heart wall actuation device for the natural heart |
US6520904B1 (en) * | 1996-01-02 | 2003-02-18 | The University Of Cincinnati | Device and method for restructuring heart chamber geometry |
US20030045771A1 (en) * | 1997-01-02 | 2003-03-06 | Schweich Cyril J. | Heart wall tension reduction devices and methods |
US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6889082B2 (en) * | 1997-10-09 | 2005-05-03 | Orqis Medical Corporation | Implantable heart assist system and method of applying same |
US6610004B2 (en) | 1997-10-09 | 2003-08-26 | Orqis Medical Corporation | Implantable heart assist system and method of applying same |
US6190408B1 (en) * | 1998-03-05 | 2001-02-20 | The University Of Cincinnati | Device and method for restructuring the heart chamber geometry |
US6733510B1 (en) | 1999-01-12 | 2004-05-11 | University Of Cincinnati | Article and method for coupling muscle to a prosthetic device |
US6110100A (en) * | 1998-04-22 | 2000-08-29 | Scimed Life Systems, Inc. | System for stress relieving the heart muscle and for controlling heart function |
US6685627B2 (en) | 1998-10-09 | 2004-02-03 | Swaminathan Jayaraman | Modification of properties and geometry of heart tissue to influence heart function |
US8715156B2 (en) * | 1998-10-09 | 2014-05-06 | Swaminathan Jayaraman | Modification of properties and geometry of heart tissue to influence function |
US6695768B1 (en) | 1999-03-30 | 2004-02-24 | Robert A. Levine | Adjustable periventricular ring/ring like device/method for control of ischemic mitral regurgitation and congestive heart disease |
JP2003510173A (en) * | 1999-09-24 | 2003-03-18 | ボシュ・アンド・ロム・インコーポレイテッド | Process for purification and reuse of solvents used to remove extractables |
US20030023132A1 (en) * | 2000-05-31 | 2003-01-30 | Melvin David B. | Cyclic device for restructuring heart chamber geometry |
EP1294305A2 (en) | 2000-05-31 | 2003-03-26 | Cardioclasp, Inc. | Devices and methods for assisting natural heart function |
US20050113798A1 (en) * | 2000-07-21 | 2005-05-26 | Slater Charles R. | Methods and apparatus for treating the interior of a blood vessel |
US6343605B1 (en) | 2000-08-08 | 2002-02-05 | Scimed Life Systems, Inc. | Percutaneous transluminal myocardial implantation device and method |
US6572534B1 (en) | 2000-09-14 | 2003-06-03 | Abiomed, Inc. | System and method for implanting a cardiac wrap |
US6846296B1 (en) | 2000-09-14 | 2005-01-25 | Abiomed, Inc. | Apparatus and method for detachably securing a device to a natural heart |
US6808483B1 (en) * | 2000-10-03 | 2004-10-26 | Paul A. Spence | Implantable heart assist devices and methods |
US6540659B1 (en) | 2000-11-28 | 2003-04-01 | Abiomed, Inc. | Cardiac assistance systems having bi-directional pumping elements |
US6602182B1 (en) | 2000-11-28 | 2003-08-05 | Abiomed, Inc. | Cardiac assistance systems having multiple fluid plenums |
US6547716B1 (en) * | 2000-11-28 | 2003-04-15 | Abiomed, Inc. | Passive cardiac restraint systems having multiple layers of inflatable elements |
US6616596B1 (en) | 2000-11-28 | 2003-09-09 | Abiomed, Inc. | Cardiac assistance systems having multiple layers of inflatable elements |
US6810882B2 (en) | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
US6702763B2 (en) | 2001-02-28 | 2004-03-09 | Chase Medical, L.P. | Sizing apparatus and method for use during ventricular restoration |
US20030181940A1 (en) * | 2001-02-28 | 2003-09-25 | Gregory Murphy | Ventricular restoration shaping apparatus and method of use |
US6622730B2 (en) | 2001-03-30 | 2003-09-23 | Myocor, Inc. | Device for marking and aligning positions on the heart |
US20020188170A1 (en) * | 2001-04-27 | 2002-12-12 | Santamore William P. | Prevention of myocardial infarction induced ventricular expansion and remodeling |
US7311731B2 (en) * | 2001-04-27 | 2007-12-25 | Richard C. Satterfield | Prevention of myocardial infarction induced ventricular expansion and remodeling |
US6626821B1 (en) | 2001-05-22 | 2003-09-30 | Abiomed, Inc. | Flow-balanced cardiac wrap |
US7485088B2 (en) * | 2001-09-05 | 2009-02-03 | Chase Medical L.P. | Method and device for percutaneous surgical ventricular repair |
US20040243170A1 (en) * | 2001-09-05 | 2004-12-02 | Mitta Suresh | Method and device for percutaneous surgical ventricular repair |
US7174896B1 (en) | 2002-01-07 | 2007-02-13 | Paracor Medical, Inc. | Method and apparatus for supporting a heart |
CA2471275A1 (en) * | 2002-01-23 | 2003-07-31 | Frederick J. Foley | Devices for holding a body organ |
US20030139645A1 (en) * | 2002-01-23 | 2003-07-24 | Adelman Thomas G. | Rotational freedom for a body organ |
US6951533B2 (en) * | 2002-02-04 | 2005-10-04 | Iotek, Inc. | Organ manipulation assistance during surgical procedure |
US20030212456A1 (en) * | 2002-05-09 | 2003-11-13 | John Lipchitz | Implant for tissue repair |
US7081084B2 (en) * | 2002-07-16 | 2006-07-25 | University Of Cincinnati | Modular power system and method for a heart wall actuation system for the natural heart |
US20040015040A1 (en) * | 2002-07-18 | 2004-01-22 | The University Of Cincinnati | Flexible, torsionable cardiac framework for heart wall actuation of the natural heart |
US7850729B2 (en) * | 2002-07-18 | 2010-12-14 | The University Of Cincinnati | Deforming jacket for a heart actuation device |
US20040059180A1 (en) * | 2002-09-23 | 2004-03-25 | The University Of Cincinnati | Basal mounting cushion frame component to facilitate extrinsic heart wall actuation |
US20040015041A1 (en) * | 2002-07-18 | 2004-01-22 | The University Of Cincinnati | Protective sheath apparatus and method for use with a heart wall actuation system for the natural heart |
US6988982B2 (en) * | 2002-08-19 | 2006-01-24 | Cardioenergetics | Heart wall actuation system for the natural heart with shape limiting elements |
US7341584B1 (en) | 2003-05-30 | 2008-03-11 | Thomas David Starkey | Device and method to limit filling of the heart |
US20060178551A1 (en) * | 2003-06-09 | 2006-08-10 | Melvin David B | Securement system for a heart actuation device |
WO2004110553A1 (en) | 2003-06-09 | 2004-12-23 | The University Of Cincinnati | Actuation mechanisms for a heart actuation device |
WO2004110257A2 (en) | 2003-06-09 | 2004-12-23 | The University Of Cincinnati | Power system for a heart actuation device |
US7513867B2 (en) * | 2003-07-16 | 2009-04-07 | Kardium, Inc. | Methods and devices for altering blood flow through the left ventricle |
AU2003904283A0 (en) * | 2003-08-12 | 2003-08-28 | Northern Sydney Area Health Service | An implantable direct cardiac compression device and system |
US20050085683A1 (en) * | 2003-10-15 | 2005-04-21 | Bolling Steven F. | Implantable heart assist system and method of applying same |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
WO2005060882A1 (en) * | 2003-12-09 | 2005-07-07 | Gi Dynamics, Inc. | Apparatus to be anchored within the gastrointestinal tract and anchoring method |
US20050131385A1 (en) * | 2003-12-12 | 2005-06-16 | Bolling Steven F. | Cannulae for selectively enhancing blood flow |
EP1720461A4 (en) * | 2004-02-13 | 2009-07-08 | Univ Cincinnati | A coupling device enabled by mechanical continuity of cellular scaffolding across tissue boundaries |
US8206439B2 (en) * | 2004-02-23 | 2012-06-26 | International Heart Institute Of Montana Foundation | Internal prosthesis for reconstruction of cardiac geometry |
US7445592B2 (en) * | 2004-06-10 | 2008-11-04 | Orqis Medical Corporation | Cannulae having reduced flow resistance |
US20050277870A1 (en) * | 2004-06-10 | 2005-12-15 | Robert Pecor | Cannula having reduced flow resistance |
US8052753B2 (en) * | 2005-01-07 | 2011-11-08 | University Of Cincinnati | Prosthetic anchor and method of making same |
US8753392B2 (en) | 2005-01-07 | 2014-06-17 | University Of Cincinnati | Elements for versatility of a prosthetic anchor |
US20060152817A1 (en) * | 2005-01-12 | 2006-07-13 | Goro Noto | Optical device |
US20060184199A1 (en) * | 2005-02-14 | 2006-08-17 | O'leary Shawn | Apparatus and methods for reducing bleeding from a cannulation site |
US20060224110A1 (en) * | 2005-03-17 | 2006-10-05 | Scott Michael J | Methods for minimally invasive vascular access |
US7715918B2 (en) * | 2005-10-18 | 2010-05-11 | University Of Cincinnati | Muscle energy converter with smooth continuous tissue interface |
US7749249B2 (en) * | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
US20070208217A1 (en) | 2006-03-03 | 2007-09-06 | Acorn Cardiovascular, Inc. | Self-adjusting attachment structure for a cardiac support device |
EP2029053B1 (en) | 2006-05-15 | 2011-02-23 | Edwards Lifesciences AG | A system for altering the geometry of the heart |
US8449605B2 (en) * | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
US8075471B2 (en) * | 2006-07-12 | 2011-12-13 | Allegheny-Singer Research Institute | Apical torsion device for cardiac assist |
US7837610B2 (en) * | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
US8529620B2 (en) | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US8092363B2 (en) * | 2007-09-05 | 2012-01-10 | Mardil, Inc. | Heart band with fillable chambers to modify heart valve function |
US20090076597A1 (en) * | 2007-09-19 | 2009-03-19 | Jonathan Micheal Dahlgren | System for mechanical adjustment of medical implants |
US20090287304A1 (en) * | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
EP2482749B1 (en) | 2009-10-01 | 2017-08-30 | Kardium Inc. | Kit for constricting tissue or a bodily orifice, for example, a mitral valve |
WO2011056981A2 (en) | 2009-11-04 | 2011-05-12 | Nitinol Devices And Components, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
US9107749B2 (en) | 2010-02-03 | 2015-08-18 | Edwards Lifesciences Corporation | Methods for treating a heart |
SE535140C2 (en) | 2010-03-25 | 2012-04-24 | Jan Otto Solem | An implantable device, kit and system for improving cardiac function, including means for generating longitudinal movement of the mitral valve |
US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
WO2012047308A1 (en) | 2010-10-08 | 2012-04-12 | Nitinol Devices And Components, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
US8932350B2 (en) | 2010-11-30 | 2015-01-13 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
AU2013328871B2 (en) | 2012-10-12 | 2018-08-16 | Diaxamed, Llc | Cardiac treatment system and method |
USD717954S1 (en) | 2013-10-14 | 2014-11-18 | Mardil, Inc. | Heart treatment device |
JP6773953B2 (en) * | 2015-02-19 | 2020-10-21 | 学校法人 久留米大学 | Auxiliary heart device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702343A (en) * | 1996-10-02 | 1997-12-30 | Acorn Medical, Inc. | Cardiac reinforcement device |
US6206820B1 (en) * | 1995-10-18 | 2001-03-27 | Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung | Device for supporting cardiac function having elastic filling chambers |
US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2826193A (en) * | 1956-08-01 | 1958-03-11 | Vineberg Heart Foundation | Cardiac resuscitation device |
US3053249A (en) * | 1959-08-25 | 1962-09-11 | Gorman Rupp Ind Inc | Cardiac massage apparatus |
FR92798E (en) * | 1966-09-05 | 1968-12-27 | Rhone Poulenc Sa | New cardiac assistance prosthesis and its manufacture. |
US3455298A (en) * | 1967-04-10 | 1969-07-15 | George L Anstadt | Instrument for direct mechanical cardiac massage |
US3590815A (en) * | 1969-01-07 | 1971-07-06 | Peter Shiff | Portable mechanical ventricular assistance device |
US3613672A (en) * | 1969-07-09 | 1971-10-19 | Peter Schiff | Mechanical ventricular assistance cup |
US3668708A (en) * | 1969-12-23 | 1972-06-13 | North American Rockwell | Artificial heart |
DE2109125A1 (en) * | 1970-03-02 | 1971-09-23 | Cabezudo, Jose Fernandez, Bilbao (Spanien) | Massage belt for vibration and musculoskeletal systems |
US3827426A (en) * | 1971-07-16 | 1974-08-06 | P Sawyer | Prosthetic pump |
US3983863A (en) * | 1975-06-02 | 1976-10-05 | American Hospital Supply Corporation | Heart support for coronary artery surgery |
US4192293A (en) * | 1978-09-05 | 1980-03-11 | Manfred Asrican | Cardiac assist device |
US4621617A (en) * | 1981-06-29 | 1986-11-11 | Sharma Devendra N | Electro-magnetically controlled artificial heart device for compressing cardiac muscle |
IT1155105B (en) * | 1982-03-03 | 1987-01-21 | Roberto Parravicini | PLANT DEVICE TO SUPPORT THE MYOCARDIUM ACTIVITY |
US4535483A (en) * | 1983-01-17 | 1985-08-20 | Hemex, Inc. | Suture rings for heart valves |
SU1191076A1 (en) * | 1984-01-04 | 1985-11-15 | Институт Механики Полимеров Ан Латвсср | Heart valve frame |
US4690134A (en) * | 1985-07-01 | 1987-09-01 | Snyders Robert V | Ventricular assist device |
FR2591489B1 (en) * | 1985-12-16 | 1988-03-25 | Aerospatiale | TOTAL HEART PROSTHESIS COMPRISING TWO PUMPING MODULES CONNECTED BY A FUNCTIONAL LINK. |
SE454942B (en) | 1986-05-22 | 1988-06-13 | Astra Tech Ab | HEART HELP DEVICE FOR INOPERATION IN BROSTHALAN |
SU1604377A1 (en) | 1987-02-23 | 1990-11-07 | Благовещенский государственный медицинский институт | Artificial pericardium |
US4925443A (en) | 1987-02-27 | 1990-05-15 | Heilman Marlin S | Biocompatible ventricular assist and arrhythmia control device |
US4809676A (en) * | 1987-12-28 | 1989-03-07 | Freeman Maynard L | Heart assist device and method of implanting it |
US4846831A (en) * | 1988-04-27 | 1989-07-11 | Skillin David E | Manual back-up drive for artificial heart |
US5139517A (en) * | 1989-11-08 | 1992-08-18 | Corral David F | Orthotopic intraventricular heart pump |
US5358519A (en) * | 1989-12-06 | 1994-10-25 | Medtronic, Inc. | Muscle control and monitoring system |
US5131905A (en) * | 1990-07-16 | 1992-07-21 | Grooters Ronald K | External cardiac assist device |
US5119804A (en) * | 1990-11-19 | 1992-06-09 | Anstadt George L | Heart massage apparatus |
US5109843A (en) * | 1990-11-30 | 1992-05-05 | University Of Cincinnati | Extra to-intracorporeal power supply |
US5169381A (en) | 1991-03-29 | 1992-12-08 | Snyders Robert V | Ventricular assist device |
US5370685A (en) * | 1991-07-16 | 1994-12-06 | Stanford Surgical Technologies, Inc. | Endovascular aortic valve replacement |
US5192314A (en) | 1991-12-12 | 1993-03-09 | Daskalakis Michael K | Synthetic intraventricular implants and method of inserting |
DE69324239T2 (en) * | 1992-01-21 | 1999-11-04 | Univ Minnesota | SEPTUAL DAMAGE CLOSURE DEVICE |
US5201880A (en) * | 1992-01-27 | 1993-04-13 | Pioneering Technologies, Inc. | Mitral and tricuspid annuloplasty rings |
US5258021A (en) * | 1992-01-27 | 1993-11-02 | Duran Carlos G | Sigmoid valve annuloplasty ring |
US5383840A (en) * | 1992-07-28 | 1995-01-24 | Vascor, Inc. | Biocompatible ventricular assist and arrhythmia control device including cardiac compression band-stay-pad assembly |
WO1994003142A1 (en) | 1992-07-30 | 1994-02-17 | Temple University - Of The Commonwealth System Of Higher Education | Direct manual cardiac compression device and method of use thereof |
US5256132A (en) * | 1992-08-17 | 1993-10-26 | Snyders Robert V | Cardiac assist envelope for endoscopic application |
US5345949A (en) | 1992-09-02 | 1994-09-13 | Shlain Leonard M | Methods for use in surgical gastroplastic procedure |
US5571176A (en) * | 1993-04-02 | 1996-11-05 | Taheri; Syde A. | Partially autogenous four chambered heart |
US5385528A (en) * | 1993-06-17 | 1995-01-31 | Wilk; Peter J. | Intrapericardial assist device and associated method |
US5533958A (en) * | 1993-06-17 | 1996-07-09 | Wilk; Peter J. | Intrapericardial assist device and associated method |
US5487760A (en) * | 1994-03-08 | 1996-01-30 | Ats Medical, Inc. | Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry |
US5593424A (en) | 1994-08-10 | 1997-01-14 | Segmed, Inc. | Apparatus and method for reducing and stabilizing the circumference of a vascular structure |
US5738627A (en) * | 1994-08-18 | 1998-04-14 | Duke University | Bi-ventricular cardiac assist device |
US5800528A (en) * | 1995-06-13 | 1998-09-01 | Abiomed R & D, Inc. | Passive girdle for heart ventricle for therapeutic aid to patients having ventricular dilatation |
US5713954A (en) * | 1995-06-13 | 1998-02-03 | Abiomed R&D, Inc. | Extra cardiac ventricular assist device |
US5749883A (en) | 1995-08-30 | 1998-05-12 | Halpern; David Marcos | Medical instrument |
US5738626A (en) * | 1996-06-14 | 1998-04-14 | Jarvik; Robert | Two-step cardiomyoplasty with ventricular reduction |
US6183411B1 (en) | 1998-09-21 | 2001-02-06 | Myocor, Inc. | External stress reduction device and method |
US6045497A (en) | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6077214A (en) | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US5961440A (en) * | 1997-01-02 | 1999-10-05 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6019722A (en) * | 1997-09-17 | 2000-02-01 | Guidant Corporation | Device to permit offpump beating heart coronary bypass surgery |
US6110100A (en) | 1998-04-22 | 2000-08-29 | Scimed Life Systems, Inc. | System for stress relieving the heart muscle and for controlling heart function |
AU745832B2 (en) | 1998-07-13 | 2002-04-11 | Acorn Cardiovascular, Inc. | Cardiac disease treatment device and method |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
-
1996
- 1996-01-02 US US08/581,914 patent/US5957977A/en not_active Expired - Fee Related
-
1997
- 1997-01-02 EP EP97901421A patent/EP0874614B1/en not_active Expired - Lifetime
- 1997-01-02 EP EP03075901A patent/EP1332766A3/en not_active Withdrawn
- 1997-01-02 WO PCT/US1997/000374 patent/WO1997024101A1/en active IP Right Grant
- 1997-01-02 CA CA002242412A patent/CA2242412C/en not_active Expired - Fee Related
- 1997-01-02 AU AU15325/97A patent/AU1532597A/en not_active Abandoned
- 1997-01-02 DE DE69725962T patent/DE69725962T2/en not_active Expired - Fee Related
- 1997-01-02 AT AT97901421T patent/ATE253346T1/en not_active IP Right Cessation
-
1998
- 1998-09-30 US US09/165,887 patent/US6221103B1/en not_active Expired - Fee Related
-
2001
- 2001-04-13 US US09/834,339 patent/US20020022880A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6206820B1 (en) * | 1995-10-18 | 2001-03-27 | Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung | Device for supporting cardiac function having elastic filling chambers |
US5702343A (en) * | 1996-10-02 | 1997-12-30 | Acorn Medical, Inc. | Cardiac reinforcement device |
US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
Cited By (148)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080029105A1 (en) * | 1993-02-22 | 2008-02-07 | Ethicon, Inc. | Minimally-invasive devices and methods for treatment of congestive heart failure |
US7213601B2 (en) | 1993-02-22 | 2007-05-08 | Heartport, Inc | Minimally-invasive devices and methods for treatment of congestive heart failure |
US6802319B2 (en) | 1993-02-22 | 2004-10-12 | John H. Stevens | Minimally-invasive devices and methods for treatment of congestive heart failure |
US20040055608A1 (en) * | 1993-02-22 | 2004-03-25 | Ethicon, Inc. | Minimally-invasive devices and methods for treatment of congestive heart failure |
US20040167374A1 (en) * | 1997-01-02 | 2004-08-26 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US20020169359A1 (en) * | 1997-01-02 | 2002-11-14 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6793618B2 (en) | 1997-01-02 | 2004-09-21 | Myocor, Inc. | Heart wall tension reduction apparatus |
US20060161040A1 (en) * | 1997-01-02 | 2006-07-20 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US20020077524A1 (en) * | 1997-01-02 | 2002-06-20 | Myocor, Inc. | Heart wall tension reduction apparatus |
US8267852B2 (en) | 1997-01-02 | 2012-09-18 | Edwards Lifesciences, Llc | Heart wall tension reduction apparatus and method |
US20090137863A1 (en) * | 1997-01-02 | 2009-05-28 | Myocor, Inc. | Heart wall tension reduction apparatus |
US7695425B2 (en) | 1997-01-02 | 2010-04-13 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US8460173B2 (en) | 1997-01-02 | 2013-06-11 | Edwards Lifesciences, Llc | Heart wall tension reduction apparatus and method |
US20100274076A1 (en) * | 1997-01-02 | 2010-10-28 | Edwards Lifesciences Llc | Heart Wall Tension Reduction Apparatus and Method |
US6755777B2 (en) | 1997-01-02 | 2004-06-29 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US20060052868A1 (en) * | 1997-12-17 | 2006-03-09 | Myocor, Inc. | Valve to myocardium tension members device and method |
US20040127983A1 (en) * | 1997-12-17 | 2004-07-01 | Myocor, Inc. | Valve to myocardium tension members device and method |
US8226711B2 (en) | 1997-12-17 | 2012-07-24 | Edwards Lifesciences, Llc | Valve to myocardium tension members device and method |
US8187323B2 (en) | 1997-12-17 | 2012-05-29 | Edwards Lifesciences, Llc | Valve to myocardium tension members device and method |
US20060195012A1 (en) * | 1997-12-17 | 2006-08-31 | Myocor, Inc. | Valve to myocardium tension members device and method |
US20080319256A1 (en) * | 1998-07-29 | 2008-12-25 | Myocor, Inc. | Transventricular implant tools and devices |
US6746471B2 (en) | 1998-07-29 | 2004-06-08 | Myocor, Inc. | Transventricular implant tools and devices |
US7981020B2 (en) | 1998-07-29 | 2011-07-19 | Edwards Lifesciences Llc | Transventricular implant tools and devices |
US20050148815A1 (en) * | 1998-07-29 | 2005-07-07 | Myocor, Inc. | Transventricular implant tools and devices |
US8439817B2 (en) | 1998-07-29 | 2013-05-14 | Edwards Lifesciences, Llc | Chordae capturing methods for stress reduction |
US7722523B2 (en) | 1998-07-29 | 2010-05-25 | Edwards Lifesciences Llc | Transventricular implant tools and devices |
US20050065396A1 (en) * | 1998-09-21 | 2005-03-24 | Myocor, Inc. | External stress reduction device and method |
US6808488B2 (en) | 1998-09-21 | 2004-10-26 | Myocor, Inc. | External stress reduction device and method |
US8579798B2 (en) | 1998-09-21 | 2013-11-12 | Edwards Lifesciences, Llc | External cardiac stress reduction method |
US20050043792A1 (en) * | 1999-06-29 | 2005-02-24 | Edwards Lifesciences Ag | Device and method for treatment of mitral insufficiency |
US7044967B1 (en) | 1999-06-29 | 2006-05-16 | Edwards Lifesciences Ag | Device and method for treatment of mitral insufficiency |
US7311728B2 (en) | 1999-06-29 | 2007-12-25 | Edwards Lifesciences Ag | Device and method for treatment of mitral insufficiency |
US20010018611A1 (en) * | 1999-06-30 | 2001-08-30 | Solem Jan Otto | Method and device for treatment of mitral insufficiency |
US20040102840A1 (en) * | 1999-06-30 | 2004-05-27 | Solem Jan Otto | Method and device for treatment of mitral insufficiency |
US8709074B2 (en) | 1999-06-30 | 2014-04-29 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6997951B2 (en) | 1999-06-30 | 2006-02-14 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US20040039443A1 (en) * | 1999-06-30 | 2004-02-26 | Solem Jan Otto | Method and device for treatment of mitral insufficiency |
US20030069636A1 (en) * | 1999-06-30 | 2003-04-10 | Solem Jan Otto | Method for treatment of mitral insufficiency |
US7192442B2 (en) | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US7090695B2 (en) | 1999-06-30 | 2006-08-15 | Edwards Lifesciences Ag | Method for treatment of mitral insufficiency |
US6612978B2 (en) | 1999-12-22 | 2003-09-02 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US6702732B1 (en) | 1999-12-22 | 2004-03-09 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US6663558B2 (en) | 1999-12-23 | 2003-12-16 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US20040102841A1 (en) * | 2000-01-31 | 2004-05-27 | Langberg Jonathan J. | Percutaneous mitral annuloplasty with cardiac rhythm management |
US7695512B2 (en) | 2000-01-31 | 2010-04-13 | Edwards Lifesciences Ag | Remotely activated mitral annuloplasty system and methods |
US20110009957A1 (en) * | 2000-01-31 | 2011-01-13 | Edwards Lifesciences Ag | Percutaneous mitral annulplasty with cardiac rhythm management |
US20040176840A1 (en) * | 2000-01-31 | 2004-09-09 | Langberg Jonathan J. | Percutaneous mitral annuloplasty with hemodynamic monitoring |
US20040133220A1 (en) * | 2000-01-31 | 2004-07-08 | Randall Lashinski | Adjustable transluminal annuloplasty system |
US20040153146A1 (en) * | 2000-01-31 | 2004-08-05 | Randall Lashinski | Methods and apparatus for remodeling an extravascular tissue structure |
US20040138744A1 (en) * | 2000-01-31 | 2004-07-15 | Randall Lashinski | Transluminal mitral annuloplasty with active anchoring |
US7935146B2 (en) | 2000-01-31 | 2011-05-03 | Edwards Lifesciences Ag | Percutaneous mitral annuloplasty with hemodynamic monitoring |
US7988726B2 (en) | 2000-01-31 | 2011-08-02 | Edward Lifesciences Llc | Percutaneous mitral annuloplasty with cardiac rhythm management |
US20020151961A1 (en) * | 2000-01-31 | 2002-10-17 | Lashinski Randall T. | Medical system and method for remodeling an extravascular tissue structure |
US20020019580A1 (en) * | 2000-03-10 | 2002-02-14 | Lilip Lau | Expandable cardiac harness for treating congestive heart failure |
US6602184B2 (en) | 2000-03-10 | 2003-08-05 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US6682474B2 (en) | 2000-03-10 | 2004-01-27 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US20030065248A1 (en) * | 2000-03-10 | 2003-04-03 | Lilip Lau | Cardiac treatment apparatus |
US6595912B2 (en) | 2000-03-10 | 2003-07-22 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US20050020874A1 (en) * | 2000-03-10 | 2005-01-27 | Lilip Lau | Expandable cardiac harness for treating congestive heart failure |
US6612979B2 (en) | 2000-03-10 | 2003-09-02 | Paracor Surgical, Inc. | Expandable cardiac harness for treating congestive heart failure |
US20060149123A1 (en) * | 2000-03-21 | 2006-07-06 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US20030050529A1 (en) * | 2000-03-21 | 2003-03-13 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US9198757B2 (en) | 2000-10-06 | 2015-12-01 | Edwards Lifesciences, Llc | Methods and devices for improving mitral valve function |
US20060241340A1 (en) * | 2000-10-06 | 2006-10-26 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US20030181928A1 (en) * | 2000-10-06 | 2003-09-25 | Myocor, Inc. | Endovascular splinting devices and methods |
US7766812B2 (en) | 2000-10-06 | 2010-08-03 | Edwards Lifesciences Llc | Methods and devices for improving mitral valve function |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US20050075723A1 (en) * | 2000-10-06 | 2005-04-07 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US20090270980A1 (en) * | 2000-10-06 | 2009-10-29 | Edwards Lifesciences Llc | Methods and Devices for Improving Mitral Valve Function |
US20050096740A1 (en) * | 2001-01-30 | 2005-05-05 | Edwards Lifesciences Ag | Transluminal mitral annuloplasty |
US8128553B2 (en) | 2001-09-07 | 2012-03-06 | Mardil, Inc. | Method and apparatus for external stabilization of the heart |
US9289298B2 (en) | 2001-09-07 | 2016-03-22 | Mardil, Inc. | Method and apparatus for external stabilization of the heart |
US20080215074A1 (en) * | 2001-09-07 | 2008-09-04 | Raman Jaishankar | Method and apparatus for external stabilization of the heart |
US8092367B2 (en) | 2001-09-07 | 2012-01-10 | Mardil, Inc. | Method for external stabilization of the base of the heart |
US8715160B2 (en) | 2001-09-07 | 2014-05-06 | Mardil, Inc. | Method and apparatus for external stabilization of the heart |
US20070129598A1 (en) * | 2001-09-07 | 2007-06-07 | Raman Jaishanker | Method and apparatus for external stabilization of the heart |
US20050014992A1 (en) * | 2001-09-10 | 2005-01-20 | Lau Lilip | Device for treating heart failure |
US20040143156A1 (en) * | 2001-09-10 | 2004-07-22 | Lilip Lau | Device for treating heart failure |
US20030153949A1 (en) * | 2001-10-31 | 2003-08-14 | Lilip Lau | Heart failure treatment device and method |
US20050033109A1 (en) * | 2001-10-31 | 2005-02-10 | Lilip Lau | Heart failure treatment device and method |
US8075616B2 (en) | 2001-12-28 | 2011-12-13 | Edwards Lifesciences Ag | Apparatus for applying a compressive load on body tissue |
US20050080483A1 (en) * | 2001-12-28 | 2005-04-14 | Solem Jan Otto | Delayed memory device |
US7976454B2 (en) | 2002-01-07 | 2011-07-12 | Paracor Medical, Inc. | Cardiac harness |
US20100185276A1 (en) * | 2002-01-09 | 2010-07-22 | Edwards Lifesciences Llc | Devices and Methods for Heart Valve Treatment |
US20060041306A1 (en) * | 2002-01-09 | 2006-02-23 | Myocor, Inc. | Devices and methods for heart valve treatment |
US8070805B2 (en) | 2002-01-09 | 2011-12-06 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US7678145B2 (en) | 2002-01-09 | 2010-03-16 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US8506624B2 (en) | 2002-01-09 | 2013-08-13 | Edwards Lifesciences, Llc | Devices and methods for heart valve treatment |
US7192443B2 (en) | 2002-01-11 | 2007-03-20 | Edwards Lifesciences Ag | Delayed memory device |
US20030135267A1 (en) * | 2002-01-11 | 2003-07-17 | Solem Jan Otto | Delayed memory device |
US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US20090156892A1 (en) * | 2002-09-05 | 2009-06-18 | Paracor Medical, Inc. | Cardiac harness |
US20040148020A1 (en) * | 2002-11-12 | 2004-07-29 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US7666224B2 (en) | 2002-11-12 | 2010-02-23 | Edwards Lifesciences Llc | Devices and methods for heart valve treatment |
US20040148019A1 (en) * | 2002-11-12 | 2004-07-29 | Vidlund Robert M. | Devices and methods for heart valve treatment |
US20050033322A1 (en) * | 2002-11-15 | 2005-02-10 | Lilip Lau | Cardiac harness delivery device and method |
US7736299B2 (en) | 2002-11-15 | 2010-06-15 | Paracor Medical, Inc. | Introducer for a cardiac harness delivery |
US20050256368A1 (en) * | 2002-11-15 | 2005-11-17 | Paracor Medical, Inc. | Introducer for a cardiac harness delivery |
US20040210104A1 (en) * | 2002-11-15 | 2004-10-21 | Lilip Lau | Cardiac harness delivery device and method |
US20070255093A1 (en) * | 2002-11-15 | 2007-11-01 | Lilip Lau | Cardiac harness delivery device and method |
US20050055032A1 (en) * | 2002-11-15 | 2005-03-10 | Lilip Lau | Cardiac harness delivery device and method |
US20050059855A1 (en) * | 2002-11-15 | 2005-03-17 | Lilip Lau | Cardiac harness delivery device and method |
US20040254600A1 (en) * | 2003-02-26 | 2004-12-16 | David Zarbatany | Methods and devices for endovascular mitral valve correction from the left coronary sinus |
US20040249242A1 (en) * | 2003-03-28 | 2004-12-09 | Lilip Lau | Multi-panel cardiac harness |
US20050283042A1 (en) * | 2003-03-28 | 2005-12-22 | Steve Meyer | Cardiac harness having radiopaque coating and method of use |
US20050054892A1 (en) * | 2003-07-10 | 2005-03-10 | Lilip Lau | Self-anchoring cardiac harness |
US7004176B2 (en) | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US20050085903A1 (en) * | 2003-10-17 | 2005-04-21 | Jan Lau | Heart valve leaflet locator |
US20050102012A1 (en) * | 2003-11-07 | 2005-05-12 | Lilip Lau | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US20050137673A1 (en) * | 2003-11-07 | 2005-06-23 | Lilip Lau | Cardiac harness having electrodes and epicardial leads |
US20070055310A1 (en) * | 2003-11-07 | 2007-03-08 | Lilip Lau | Cardiac harness for treating heart disease |
US20070106359A1 (en) * | 2003-11-07 | 2007-05-10 | Alan Schaer | Cardiac harness assembly for treating congestive heart failure and for pacing/sensing |
US20050102010A1 (en) * | 2003-11-07 | 2005-05-12 | Lilip Lau | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US20050171589A1 (en) * | 2003-11-07 | 2005-08-04 | Lilip Lau | Cardiac harness and method of delivery by minimally invasive access |
US20070112390A1 (en) * | 2003-11-07 | 2007-05-17 | Lilip Lau | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US20070106336A1 (en) * | 2003-11-07 | 2007-05-10 | Alan Schaer | Cardiac harness assembly for treating congestive heart failure and for pacing/sensing |
US20050102013A1 (en) * | 2003-11-07 | 2005-05-12 | Lilip Lau | Cardiac harness for treating heart disease |
US20090043152A1 (en) * | 2003-11-07 | 2009-02-12 | Paracor Medical, Inc. | Delivery device for cardiac harness |
US20050119717A1 (en) * | 2003-11-07 | 2005-06-02 | Lilip Lau | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US20050177228A1 (en) * | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
US20050154253A1 (en) * | 2004-01-12 | 2005-07-14 | Lilip Lau | Cardiac harness having interconnected strands |
US20080027274A1 (en) * | 2004-01-12 | 2008-01-31 | Paracor Medical, Inc. | Cardiac harness having interconnected strands |
US7993397B2 (en) | 2004-04-05 | 2011-08-09 | Edwards Lifesciences Ag | Remotely adjustable coronary sinus implant |
US20050222678A1 (en) * | 2004-04-05 | 2005-10-06 | Lashinski Randall T | Remotely adjustable coronary sinus implant |
US20060009675A1 (en) * | 2004-07-08 | 2006-01-12 | Steven Meyer | Self-anchoring cardiac harness for treating the heart and for defibrillating and/or pacing/sensing |
US20070055091A1 (en) * | 2004-12-02 | 2007-03-08 | Lilip Lau | Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing |
US20060129051A1 (en) * | 2004-12-09 | 2006-06-15 | Rowe Stanton J | Diagnostic kit to assist with heart valve annulus adjustment |
US20070168023A1 (en) * | 2004-12-09 | 2007-07-19 | Rowe Stanton J | Diagnostic kit to assist with heart valve annulus adjustment |
US7806928B2 (en) | 2004-12-09 | 2010-10-05 | Edwards Lifesciences Corporation | Diagnostic kit to assist with heart valve annulus adjustment |
US20060129026A1 (en) * | 2004-12-15 | 2006-06-15 | Joshua Wallin | Apparatus and method for mounting a cardiac harness on the heart |
US20060247491A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for heart valve treatment |
US20070032696A1 (en) * | 2005-07-22 | 2007-02-08 | Sieu Duong | Cardiac harness delivery device |
US20070027516A1 (en) * | 2005-08-01 | 2007-02-01 | Alan Schaer | Cardiac harness having an optimal impedance range |
US9375218B2 (en) | 2006-05-03 | 2016-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US10595861B2 (en) | 2006-05-03 | 2020-03-24 | Datascope Corp. | Systems and methods of tissue closure |
US11369374B2 (en) | 2006-05-03 | 2022-06-28 | Datascope Corp. | Systems and methods of tissue closure |
US20070287883A1 (en) * | 2006-06-07 | 2007-12-13 | Lilip Lau | Apparatus and method for pulling a cardiac harness onto a heart |
US20090048480A1 (en) * | 2007-08-13 | 2009-02-19 | Paracor Medical, Inc. | Cardiac harness delivery device |
US8192351B2 (en) | 2007-08-13 | 2012-06-05 | Paracor Medical, Inc. | Medical device delivery system having integrated introducer |
US20100298935A1 (en) * | 2007-09-12 | 2010-11-25 | Surgical Energetics, Inc. | Medical Device and Tension Member for Use in a Subject |
US9492270B2 (en) | 2007-09-12 | 2016-11-15 | Alan Joel Melvin | Medical device and tension member for use in a subject |
US20110004053A1 (en) * | 2007-12-05 | 2011-01-06 | Surgical Energetics, Inc. | bolster for securing a septal splint to a cardiac wall, a method of use thereof, and a system including the same |
US20090281372A1 (en) * | 2008-05-06 | 2009-11-12 | Paracor Medical, Inc. | Cardiac harness assembly for treating congestive heart failure and for defibrillation and/or pacing/sensing |
US10485545B2 (en) | 2013-11-19 | 2019-11-26 | Datascope Corp. | Fastener applicator with interlock |
US11564689B2 (en) | 2013-11-19 | 2023-01-31 | Datascope Corp. | Fastener applicator with interlock |
US11653928B2 (en) | 2018-03-28 | 2023-05-23 | Datascope Corp. | Device for atrial appendage exclusion |
Also Published As
Publication number | Publication date |
---|---|
ATE253346T1 (en) | 2003-11-15 |
EP0874614A1 (en) | 1998-11-04 |
AU1532597A (en) | 1997-07-28 |
DE69725962D1 (en) | 2003-12-11 |
WO1997024101A1 (en) | 1997-07-10 |
EP1332766A2 (en) | 2003-08-06 |
DE69725962T2 (en) | 2004-05-06 |
US5957977A (en) | 1999-09-28 |
US6221103B1 (en) | 2001-04-24 |
CA2242412A1 (en) | 1997-07-10 |
CA2242412C (en) | 2002-04-30 |
EP1332766A3 (en) | 2004-01-07 |
EP0874614B1 (en) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6221103B1 (en) | Device and method for restructuring heart chamber geometry | |
US6520904B1 (en) | Device and method for restructuring heart chamber geometry | |
US6190408B1 (en) | Device and method for restructuring the heart chamber geometry | |
US7361191B2 (en) | Heart wall actuation device for the natural heart | |
US6179791B1 (en) | Device for heart measurement | |
US6572533B1 (en) | Cardiac disease treatment and device | |
US6896652B2 (en) | Cardiac disease treatment and device | |
EP1638627B1 (en) | Device for proactive modulation of cardiac strain patterns | |
US20030023132A1 (en) | Cyclic device for restructuring heart chamber geometry | |
US20040059180A1 (en) | Basal mounting cushion frame component to facilitate extrinsic heart wall actuation | |
JP2022540406A (en) | Cardiac chamber prostheses and related cardiac assist systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |